Company / Total Assets
Phio Pharmaceuticals Corp. Total Assets History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$15.7M
FY2020
5-year range
$4.1M / $15.7M
FY2016-FY2020
Trend
+95.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 7 years, ranging from $4M in FY2017 to $16M in FY2020.
Based on SEC 10-K filings.
$16M in FY2020 with a 3-year CAGR of +56.6%.
Improved from $15M to $16M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +56.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +56.6%, indicating consistent growth.
- In FY2020, total assets increased 95.8% year-over-year.
- Lowest total assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $15.7M | +95.8% |
| FY2019 | $8.0M | -47.5% |
| FY2018 | $15.3M | +273.9% |
| FY2017 | $4.1M | -69.4% |
| FY2016 | $13.4M | -10.3% |
| FY2013 | $14.9M | +167.1% |
| FY2012 | $5.6M | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026